
The rationale behind a vaccine based on multiple HIV antigens
Keywords: HIV-1; DNA vaccine; Clinical trials; CTL; cytotoxic T-lymphocyte; GMP; good manufacturing practice; GM-CSF; granulocyte macrophage-colony stimulating factor; IFN-γ; interferon-γ; MGV; mean gray values; MuLV; murine leukemia virus; rGM-CSF; recombinant G